Red blood cell labeling with technetium-99m. Effect of radiopaque contrast agents.
Radiographic contrast agents have been reported in the literature to interfere significantly with red blood cell (RBC) labeling in vivo by Tc-99m. Moreover, in the presence of contrast agents, red cells have been known to undergo significant morphologic changes. These observations led to the current RBC labeling study in patients (N = 25) undergoing procedures with the administration of contrast media. Before and after contrast administration, blood samples were drawn from each patient into vacutainer tubes containing heparin and RBC labeling was performed using 1-ml aliquots of these samples following the Brookhaven National Laboratory protocol. The differences in average percentage labeling yield with and without contrast media were not significant. In vivo labeling in hypertensive rats with administration of contrast media up to 600 mg likewise consistently gave high labeling yields at all concentrations. Purported alterations in cell labeling attributed to contrast agents are not reflected in these studies, and other pathophysiologic factors need to be identified to substantiate the previous reports. In vitro study offers a potentially useful and simple method to delineate effects of various agents on cell labeling.
Finkel
J
J
Department of Nuclear Medicine, Albert Einstein College of Medicine, Bronx, New York 10461.
Chervu
L R
LR
Bernstein
R G
RG
Srivastava
S C
SC
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D003287:Contrast Media / Q000494:pharmacology*; D003973:Diatrizoate / Q000494:pharmacology; D004347:Drug Interactions; D004912:Erythrocytes / Q000000981:diagnostic imaging* / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000000981:diagnostic imaging / Q000378:metabolism; D008875:Middle Aged; D011877:Radionuclide Imaging; D011897:Random Allocation; D051381:Rats; D013667:Technetium / Q000494:pharmacology*
D003287:Contrast Media; D003973:Diatrizoate; D013667:Technetium